This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Credit card perks can vary widely, but knowing what to expect helps you choose wisely. Learn to maximize rewards and enjoy valuable benefits.
13,171 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A celebrity DM moment becomes a smart-money lesson. This article uses the idea of erling haaland finally accepts an i...
Analysts push a higher target for NVIDIA as demand for Blackwell and Vera Rubin accelerates. The latest guidance sign...
Datadog's CEO recently sold a sizable block of shares. This article breaks down the numbers, explains why insiders se...
Symbotic's shiny narrative has investors buzzing, but the biggest gains often hinge on real execution, not just optim...
A new mega-listing grabbed headlines by raising $26.5 billion, ranking just below SpaceX in U.S. market history. Read...
Global defense budgets are expanding, driving gains in aerospace and defense equities. The ITA ETF offers access to a...
Memory chips power today’s data centers, AI accelerators, and personal devices. This guide breaks down the case for S...
A surge of optimism surrounds NVIDIA's latest driverless advances and what they mean for Uber stock investors. This p...
Bill Ackman's closed-end fund recently trades at a sizable discount, prompting questions about a Berkshire-style bet....
Federal Reserve Governor Christopher Waller signaled that he does not support additional rate hikes for now and expec...
After a quarterly report, Netflix's post-earnings sell-off just highlighted a shift in strategy. This article breaks ...